Search results
Jan 20, 2022 · Dengue Vaccine Recommendations. Sanofi-Pasteur will stop manufacturing its dengue vaccine for children. The manufacturer is discontinuing the vaccine citing a lack of demand in the global market to continue production of this vaccine. CDC, in collaboration with the Puerto Rico Department of Health, will continue alerting health professionals ...
Feb 2, 2024 · Currently, there are two other other dengue vaccines approved for use and recommended by the World Health Organization: Dengvaxia (3 doses) and TAK-003 (2 doses). Dengvaxia, however, is recommended only for use in children and adults ages 9 to 45 with at least one documented case of dengue, as dengue-naive recipients can suffer antibody ...
Aug 8, 2023 · DENGVAXIA For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratoryconfirmed ...
Nov 29, 2019 · Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analyses have shown that vaccine performance is ...
May 14, 2024 · A vaccine can help prevent all four dengue viruses (serotypes). Dengvaxia is the only dengue vaccine approved for use in the United States. The dengue vaccine is recommended for routine use among children aged 9–16 years with laboratory-confirmed previous dengue virus infection and living in areas where dengue is endemic.
Dec 16, 2021 · Methods. The Dengue Vaccines Work Group met bimonthly from October 2018 through April 2021 to review Dengvaxia data from clinical trials. The work group comprised ACIP members, including the chair; the CDC lead from the Division of Vector-Borne Disease’s Dengue Branch; experts in dengue and flavivirus epidemiology and vaccinology; representatives of the American Academy of Pediatrics and the ...
Mar 29, 2022 · Dengue, the main arboviral disease worldwide,1 is a disease of high epidemiological impact caused by serotypes 1, 2, 3, or 4 of dengue virus.2 At least 60 million symptomatic infections occur annually worldwide, resulting in about 10 000 deaths. More than 4 billion people are at risk in countries that present optimal conditions for Aedes spp mosquitoes—the key vector of dengue virus.3 Thus ...
